Boeing Earnings Are Coming. What to Expect.

Boeing will report third-quarter earnings Wednesday morning. The company’s results have been notably hard to predict in recent years. Investors should focus on cash flow.

Predicting Boeing’s third quarter isn’t an easy call. Lately, Boeing has had trouble ramping up production of its 737 MAX jets, partly due to supplier problems—which Boeing is directly addressing. That is weighing on Wall Street’s near-term estimates. The Spirit Aero problem is another thing investors have to factor into third-quarter numbers. Analysts now project a per-share loss of $3.18 for the third quarter. A few weeks back, that number was a loss of about 50 cents. Boeing lost 82 cents a share in the second quarter.Newsletter Sign-up Performance from Boeing’s defense business has been uneven recently too: It reported operating losses in seven of the past nine quarters, according to FactSet.

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Production woes plague earnings for Boeing, RTX and Spirit AeroProduction woes plague earnings for Boeing, RTX and Spirit Aero
Herkunft: Investingcom - 🏆 450. / 53 Weiterlesen »

GE Earnings Are Coming. What to Expect.Investors will be looking for a guidance boost and an update on the GE Vernova spinoff.
Herkunft: MarketWatch - 🏆 3. / 97 Weiterlesen »

Boeing Earnings Are Coming. Here’s What to Expect.Results from the commercial aerospace giant have been uneven lately, to say the least.
Herkunft: MarketWatch - 🏆 3. / 97 Weiterlesen »

Visa's stock up 2% on earnings beat; card giant says consumers are 'resilient'‘Confident in our ability to deliver against a backdrop of geopolitical and economic uncertainty,’ Visa says
Herkunft: MarketWatch - 🏆 3. / 97 Weiterlesen »

Visa earnings: What to expect from the payments giantVisa reports fiscal fourth-quarter results after the close of trading Tuesday
Herkunft: MarketWatch - 🏆 3. / 97 Weiterlesen »

We're buying more of this life sciences stock after an earnings-driven declineThe stock is under pressure in early trading due to uncertainty around the recovery in a key business.
Herkunft: CNBC - 🏆 12. / 72 Weiterlesen »